Indication
Neonatal Sepsis
8 clinical trials
10 products
Clinical trial
A Multicenter, Open-label, Single-arm, Multiple-dose Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Ceftobiprole Medocaril in Term and Pre-term Neonates and Infants up to 3 Months of Age With Late-onset SepsisStatus: Recruiting, Estimated PCD: 2024-12-01
Product
CeftobiproleClinical trial
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations With High Risk for EOSStatus: Recruiting, Estimated PCD: 2026-07-01
Product
AmpicillinProduct
GentamycinProduct
Normal salineClinical trial
Intravenous Methylene Blue for Treating Fluid-refractory, Catecholamine-resistant, Neonatal Septic Shock: a Randomized, Placebo-controlled, Superiority TrialStatus: Not yet recruiting, Estimated PCD: 2026-03-14
Product
Methylene BlueClinical trial
Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)Status: Completed, Estimated PCD: 2022-09-06
Product
Vitamin DClinical trial
Use of Probiotics to Reduce Infections and Death and Prevent Colonization With Extended-spectrum Beta-lactamase Producing Bacteria, Among Newborn Infants in Haydom and Surrounding Area, Tanzania, a Randomized Controlled Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2023-07-10
Product
LabinicClinical trial
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates At-risk of Early-onset Bacterial Sepsis: a Multicentric, Randomized, Controlled, Non-inferiority Trial (the SAUNA Trial)Status: Not yet recruiting, Estimated PCD: 2027-04-15
Product
AntibioticsClinical trial
Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal SepsisStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
Antibiotic